激肽释放酶14抗体

激肽释放酶14抗体产品标准

浓缩液(1mg/1ml) 亲和纯化抗体

产品应用

WB=1:100-500 Elisa =1:200-1000 IP=1:20-100 IHC=1:100-500 （石蜡切片需做抗原修复）

激肽释放酶14抗体产品介绍

KLK14目前认为在宫颈鳞癌和腺癌中都有表达,是很有意义的标志物。激肽释放酶KLK是激肽系统的主要限速酶，它是一组存在于多数组织和体液中的丝氨酸蛋白酶，是一种肽链内切酶。KLK又称血管舒缓素，包括15个家族成员。在不同的组织中广泛表达,具有蛋白水解酶的活性。它特异性的在碳末端切割底物肽，可裂解激肽原释放具有活性的激肽，由激肽发挥对心血管系统及肾脏功能的调节作用。
The human tissue Kallikrein gene family encodes 15 serine proteases. All Kallikreins share structural similarities including cysteine residues, a catalytic triad of His, Asp and Ser residues, typically five coding exons, and varied intron phases. Kallikreins are predominantly secreted as inactive zymogens prior to activation by cleavage of an N-terminal peptide and all function extracellularly. Kallikreins can be activated autocatalytically, via other Kallikreins, or additional proteases. While structurally similar, Kallikrein family members have distinct functions and have key roles in many physiological and pathological processes. Many human tissue Kallikreins also show promise as cancer biomarkers, which may facilitate earlier detection and characterization of many forms of cancer.
Kallikrein 14, also known as kallikrein-like6 (KLK-L6), is a trypsin-like serine proteinase. Kallikrein 14 was discovered by cloning the kallikrein locus on chromosome 19 and was found to be similar to the other kallikrein family genes. Kallikrein 14 is produced by a number of tissues, including the brain, spinal cord, esophagus, salivary gland, breast, prostate, uterus, lung, thymus and thyroid. Like many of the kallikreins, Kallikrein 14 is also found in biological fluids like serum, breast milk, amniotic fluid, seminal plasma and cerebrospinal fluid. Kallikrein 14 message has been reported to be decreased in some breast cancers and in ovarian cancers, similar to Kallikrein 10. Some cell lines express Kallikrein 14 in culture and like many of the kallikreins, the production is stimulated by hormones. Recombinant kallikrein 14 was profiled on peptide substrates and found to possess both trypsin-like and chymotrypsin-like activity. The ECM proteins lamanin and collagen-IV are thought to be substrates of Kallikrein 14. Endogenous inhibitors include kallistatin, protein-C inhibitor and alpha1-proteinase inhibitor, although Kallikrein 14 can be found complexed to a number of different proteinase inhibitors.
mol wt:28kDa
Other Aliases:
Kallikrein 14; kallikrein-related peptidase 14; hK14; Kallikrein-like protein 6; KLK-L6; KLKL6; GK14; MGC157618xy-0161R p75 NGF Receptor神经生长因子受体抗体
xy-8579R PMS1肿瘤错配修复基因PMS1抗体
xy-9446R AMPKγ2腺苷单磷酸活化蛋白激酶γ2抗体
xy-9900R PAFAH1B2血小板衍化生长因子β抗体
xy-9901R PAFAHG血小板衍化生长因子γ抗体
xy-9902R p47血小板47蛋白抗体
xy-9916R PAPP A2妊娠相关血浆蛋白A2抗体
xy-9917R PGCP血浆谷氨酸羧肽酶抗体
xy-3704R phospho-P53(Ser315)磷酸化肿瘤抑制基因P53抗体
xy-0891R Pokemon扑克蒙蛋白抗体
xy-0588R PALB2乳腺癌易感基因相关蛋白2
xy-1299R Parvalbumin细小清蛋白抗体
xy-9524R PIGA红细胞磷脂酰肌醇聚糖A抗体
xy-11124R PCDHA11原钙粘蛋白11抗体
xy-2301R CD162P选择素糖蛋白配体1抗体
xy-0875R PKN2蛋白激酶N2抗体
xy-1209R GRK2G蛋白偶合受体激酶2抗体
xy-11291R PHC2早期发育调控蛋白2抗体
xy-4702R Phospholipase C beta 3磷酯酶Cβ3
xy-10073R PDGF-A血小板源性生长因子A抗体
xy-4967R PAPOLB睾丸特异性核苷酸果糖β抗体
xy-9942R C11orf7311号染色体开放阅读框73抗体
xy-11306R PCYT1A 磷酸乙醇胺转移酶A抗体
xy-11307R Prostaglandin I2 Receptor前列环素受体抗体
xy-11085R PCDH7原钙粘蛋白7抗体
xy-8584R PXMP1过氧化物酶膜蛋白1抗体
xy-11063R Plakophilin 2桥粒斑菲素蛋白2抗体
xy-11062R PSCDBP胞粘蛋白结合调节蛋白抗体
xy-11574R PCTAIRE2丝氨酸/苏氨酸蛋白激酶PCTK2抗体
xy-11575R PDE7A磷酸二酯酶7抗体
xy-11576R PDE7B磷酸二酯酶7B抗体
xy-11577R PHOX2A先天性眼外肌纤维化相关蛋白FEOM2抗体
激肽释放酶14抗体